CD4 and primary progressive multiple sclerosis: Here, we showed that treatment of people with primary progressive multiple sclerosis with OCR not only depletes both B cells and CD20dim T cells in the PBMC fraction but is also associated with a significant reduction of total B cells and especially CD4+ CD20dim CD45RA− memory T cells in the CSF.